Bessemer Venture Partners

Founded in 1911, Bessemer Venture Partners is a venture capital firm based in Redwood City, California. With over $4 billion under management, the firm invests globally across various sectors including artificial intelligence & machine learning, biotech, cloud, consumer, cybersecurity, deep tech, developer, fintech, healthcare, marketplaces, and vertical software. Known for its long-standing support of entrepreneurs, Bessemer has backed companies such as Pinterest, Shopify, Twilio, Yelp, and Linkedin.

Eric Arnold

Vice President

Kent Bennett

Partner

Thomas Berger

Partner

Charles Birnbaum

Partner

Sam Bondy

Investor

Past deals in Healthcare

Plenful

Series B in 2025
Plenful is a San Francisco-based company that specializes in optimizing healthcare and pharmacy operations through its AI-powered automation software. The platform focuses on automating repetitive and manual workflows, enhancing efficiency and data accuracy in administrative healthcare operations. By leveraging intelligent workflow automation and machine learning, Plenful aims to alleviate the burden on healthcare staff, resulting in significant savings in time and costs. The company's solutions contribute to improved financial and operational outcomes, ultimately fostering more efficient patient care. Plenful is supported by prominent investors in the healthcare and software sectors.

The Applied AI Company (AAICO)

Series A in 2025
The Applied AI Company builds products to automate human processes within insurance, pharmaceutical, healthcare and government. AAICO’s products help reduce human error, remove manual processes and upgrade productivity.

Qventus

Series D in 2025
Qventus is an AI-powered software platform that optimizes hospital operations using real-time data analytics. The platform predicts issues, provides immediate recommendations, and prompts action by clinical and operations teams across emergency departments, operating rooms, preoperative areas, inpatient and outpatient settings, patient safety, and pharmacy. By turning data into actionable insights, it reduces manual work, improves patient flow, and optimizes resource use to unlock capacity and support hospital revenue. Based in Los Altos, California, Qventus was formerly analyticsMD

Torch Dental

Venture Round in 2025
Torch Dental offers an all-in-one digital platform for dental practices to manage supply ordering and inventory efficiently. It simplifies the ordering process, allowing dentists to focus more on patient care.

Vapi

Series A in 2024
Vapi is a platform that allows the integration of applications and services. It enables users to create, manage, and monitor APIs. It also supports developers in building solutions and facilitates collaboration between teams. Vapi serves industries such as technology, finance, healthcare, and logistics.

Boldfit

Series A in 2024
Boldfit is a direct-to-consumer brand that specializes in fitness products, offering a range of gym equipment and nutritional supplements to support your fitness journey. Its fitness product categories include resistance bands, yoga mats, bottles and shakers, and home gym accessories. Bold Fit also provides proteins, recovery, and intra supplements, as well as daily essentials, omega 3, detox, bone, and joint health nutrition supplements.

CopilotIQ

Series B in 2024
CopilotIQ offers remote monitoring solutions for chronic conditions such as high blood pressure, diabetes, and heart disease. It collects daily patient data to identify potential health issues and facilitate improvements, aiming to enhance patients' well-being with reduced medication.

Oshi Health

Series C in 2024
Oshi Health is a virtual gastroenterology clinic specializing in diagnosing, treating, and remotely monitoring digestive conditions. Patients work with an integrated team of specialists to determine the root causes of symptoms and develop personalized care plans combining medication, dietary interventions, and gut-brain behavioral therapy.

Plenful

Series A in 2024
Plenful is a San Francisco-based company that specializes in optimizing healthcare and pharmacy operations through its AI-powered automation software. The platform focuses on automating repetitive and manual workflows, enhancing efficiency and data accuracy in administrative healthcare operations. By leveraging intelligent workflow automation and machine learning, Plenful aims to alleviate the burden on healthcare staff, resulting in significant savings in time and costs. The company's solutions contribute to improved financial and operational outcomes, ultimately fostering more efficient patient care. Plenful is supported by prominent investors in the healthcare and software sectors.

Smarter Technologies

Series B in 2024
Smarter Technologies is a healthcare technology company that provides AI-driven revenue cycle management and revenue integrity solutions for hospitals. Its clinical AI platform analyzes patient charts using physician-developed algorithms to identify missing or incorrect diagnoses, generate evidence-backed appeal letters, and integrate with existing workflows without requiring replacement. The platform delivers real-time insights into care documentation and helps hospitals recover missed revenue, improve quality metrics, and reduce administrative burden associated with denied claims.

Abridge

Series C in 2024
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

Abridge

Series B in 2023
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.

Carefull

Series A in 2023
Carefull is a company dedicated to supporting adult children who manage their aging parents' finances. They offer digital services aimed at simplifying financial caregiving tasks and enhancing family financial decision-making.

Plenful

Seed Round in 2023
Plenful is a San Francisco-based company that specializes in optimizing healthcare and pharmacy operations through its AI-powered automation software. The platform focuses on automating repetitive and manual workflows, enhancing efficiency and data accuracy in administrative healthcare operations. By leveraging intelligent workflow automation and machine learning, Plenful aims to alleviate the burden on healthcare staff, resulting in significant savings in time and costs. The company's solutions contribute to improved financial and operational outcomes, ultimately fostering more efficient patient care. Plenful is supported by prominent investors in the healthcare and software sectors.

Mural Health

Seed Round in 2023
Mural Health develops technology for clinical trials to simplify participation and improve enrollment and retention in studies. Founded in 2022 and based in Berwyn, Pennsylvania, the company creates clinical research tools designed to ease global participation. Its initial feature set includes transportation coordination, multi-way messaging, and participant feedback, enabling healthcare professionals to manage the trial experience for patients and caregivers and reduce barriers to enrolling in and remaining in trials.

Oshi Health

Series B in 2023
Oshi Health is a virtual gastroenterology clinic specializing in diagnosing, treating, and remotely monitoring digestive conditions. Patients work with an integrated team of specialists to determine the root causes of symptoms and develop personalized care plans combining medication, dietary interventions, and gut-brain behavioral therapy.

Folx Health

Series B in 2022
Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Abridge

Series A in 2022
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.

Turquoise Health

Series A in 2022
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

MediSage

Funding Round in 2022
Medisage is a global community of Doctors Connect with Global doctors, watch video case studies by subject matter experts, read latest medical news and discuss patient cases.

House Rx

Series A in 2022
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Rupa Health

Series A in 2022
Rupa Health operates an online platform that facilitates access to alternative healthcare providers and streamlines the process of ordering lab tests. Founded in 2018 and based in San Francisco, the company offers a comprehensive service that enables doctors to order specialty lab work, manage samples, and receive results efficiently. The platform integrates seamlessly with various lab companies, allowing healthcare professionals to order multiple tests in one place without requiring membership or subscription fees. Rupa Health also provides flexible payment options and robust support for both practitioners and patients, ensuring an efficient lab experience. The company's services include shipping test reports directly to patients' homes, simplifying the management and tracking of lab results to enhance patient care.

Qventus

Private Equity Round in 2022
Qventus is an AI-powered software platform that optimizes hospital operations using real-time data analytics. The platform predicts issues, provides immediate recommendations, and prompts action by clinical and operations teams across emergency departments, operating rooms, preoperative areas, inpatient and outpatient settings, patient safety, and pharmacy. By turning data into actionable insights, it reduces manual work, improves patient flow, and optimizes resource use to unlock capacity and support hospital revenue. Based in Los Altos, California, Qventus was formerly analyticsMD

MediBuddy

Series C in 2022
MediBuddy is a digital healthcare platform that facilitates access to various services such as online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, anytime, anywhere.

NephroPlus

Series E in 2021
NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

Rimsys

Series A in 2021
Rimsys is a leading provider of Regulatory Information Management (RIM) software specifically designed for medical technology companies. The software is tailored for regulatory affairs professionals, enabling them to digitize and automate compliance processes to meet evolving global regulations. Rimsys offers a comprehensive solution that manages global Unique Device Identification (UDI) requirements and facilitates the navigation of essential regulatory components, including product registration, standards management, and regulatory intelligence. By actively tracking product registrations and monitoring relevant technical files and standards, Rimsys simplifies regulatory management for clients, transforming their operations into a more organized and efficient system for teams and international partners.

Oshi Health

Series A in 2021
Oshi Health is a virtual gastroenterology clinic specializing in diagnosing, treating, and remotely monitoring digestive conditions. Patients work with an integrated team of specialists to determine the root causes of symptoms and develop personalized care plans combining medication, dietary interventions, and gut-brain behavioral therapy.

Torch Dental

Funding Round in 2021
Torch Dental offers an all-in-one digital platform for dental practices to manage supply ordering and inventory efficiently. It simplifies the ordering process, allowing dentists to focus more on patient care.

Nova Benefits

Series A in 2021
Nova Benefits operates a B2B health benefits platform focused on corporate health insurance, helping companies design and manage employee health programs. The platform aims to save HR time by automating workflows and offers a suite of services including health insurance, doctor consultations, claim settlements, mental wellness, fitness and chronic care programs to deliver personalized benefits for employees.

Nym

Venture Round in 2021
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Turquoise Health

Seed Round in 2021
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

Clearing

Seed Round in 2021
Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Groups Recover Together

Series C in 2021
Groups Recover Together, Inc. is a healthcare provider specializing in the treatment of opioid addiction through a combination of medication-assisted treatment and therapeutic services. Founded in 2014 and headquartered in Manchester, New Hampshire, the company operates private clinics across several states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its services include the administration of Suboxone (buprenorphine), weekly group therapy sessions, and personalized support to help patients set and achieve life goals. By fostering a supportive community, Groups Recover Together aims to empower individuals to regain control of their lives and pursue long-term recovery from opiate use disorder.

Carefull

Seed Round in 2021
Carefull is a company dedicated to supporting adult children who manage their aging parents' finances. They offer digital services aimed at simplifying financial caregiving tasks and enhancing family financial decision-making.

Folx Health

Series A in 2021
Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

MediBuddy

Series B in 2021
MediBuddy is a digital healthcare platform that facilitates access to various services such as online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, anytime, anywhere.

TScan Therapeutics

Series C in 2021
TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Folx Health

Venture Round in 2021
Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Aspen RxHealth

Series B in 2021
Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists with patients based on various social and clinical criteria, including language and medication regimens. The platform enables health plans and providers to efficiently link their patients to a community of pharmacists who can offer specialized clinical services, ranging from comprehensive medication reviews to targeted interventions. By optimizing communication and simplifying processes, Aspen RxHealth aims to improve patient outcomes and enhance the delivery of pharmaceutical care.

Hinge Health

Series D in 2021
Hinge Health is a digital health company that designs and delivers technology-enabled musculoskeletal care for employees and self-insured employers. The platform combines wearable sensors, computer vision and a clinical team to provide digital physical therapy, guidance on behavior change, and access to orthopedic expertise via a single app. It targets back, neck, shoulder and joint pain and aims to improve access to high-quality care while reducing costs for clients. The solution supports self-management with remote monitoring and personalized programs, enabling physical therapists, health coaches and surgeons to coordinate care. Founded in 2015 and headquartered in San Francisco, it serves businesses and individuals seeking scalable MSK treatment and prevention.

Hinge Health

Venture Round in 2020
Hinge Health is a digital health company that designs and delivers technology-enabled musculoskeletal care for employees and self-insured employers. The platform combines wearable sensors, computer vision and a clinical team to provide digital physical therapy, guidance on behavior change, and access to orthopedic expertise via a single app. It targets back, neck, shoulder and joint pain and aims to improve access to high-quality care while reducing costs for clients. The solution supports self-management with remote monitoring and personalized programs, enabling physical therapists, health coaches and surgeons to coordinate care. Founded in 2015 and headquartered in San Francisco, it serves businesses and individuals seeking scalable MSK treatment and prevention.

Aspen RxHealth

Venture Round in 2020
Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists with patients based on various social and clinical criteria, including language and medication regimens. The platform enables health plans and providers to efficiently link their patients to a community of pharmacists who can offer specialized clinical services, ranging from comprehensive medication reviews to targeted interventions. By optimizing communication and simplifying processes, Aspen RxHealth aims to improve patient outcomes and enhance the delivery of pharmaceutical care.

Nym

Series A in 2020
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Abridge

Series A in 2020
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.

NeueHealth

Series E in 2020
NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

Breathwrk

Seed Round in 2020
Breathwrk develops a mobile application offering science-backed guided breathing exercises. Users can manage mental wellness by reducing anxiety, improving sleep, enhancing focus, and boosting energy.

Stuff That Works

Seed Round in 2020
Founded in 2018, Stuff That Works develops an AI-based online platform that crowdsources data on chronic disease treatments. It offers a web-based questionnaire for quantitative analysis, publishing insights on conditions like clinical depression, diabetes, and fibromyalgia. The platform enables users to discuss insights and contributes to ongoing research.

DocsApp

Series B in 2020
DocsApp is an online doctor consultation platform. DocsApp is a mobile platform where people from India can consult a specialist MD Doctors with in 30 minutes in various specialisations through chat or call from the location of their convenience. DocsApp has specialist Doctors in the following specialisations.

HelloRelish

Series A in 2020
HelloRelish Ltd. is a relationship wellness company that specializes in developing a training application designed for text-based coaching and personalized improvement plans. The company's flagship product, Relish, functions as a personal trainer for relationships, creating customized training plans tailored to individual circumstances through a comprehensive library of content and activities. Utilizing micro-learning techniques and machine learning, Relish provides empirically proven advice that is timely, tailored, and action-oriented, ensuring users remain accountable in their relationship improvement journey. Founded in 2018, HelloRelish is headquartered in Mamaroneck, New York.

Folx Health

Venture Round in 2020
Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Abridge

Pre Seed Round in 2020
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations, turning patient-clinician discussions into structured clinical notes in real time and integrating with electronic health record systems. The platform reduces manual note-taking, improves documentation accuracy, and enhances patient understanding by providing clear, understandable summaries. It supports clinicians across clinical, nursing, and revenue cycle workflows while prioritizing data security and patient privacy and complying with healthcare regulations. The system offers an audio-based recording and summarization approach with a customizable interface to tailor notes to patient needs.

Fractyl Health

Venture Round in 2020
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Kymera Therapeutics

Series C in 2020
Kymera Therapeutics is a biotechnology company focused on targeted protein degradation. It employs a proprietary predictive modeling platform to discover novel small molecule therapeutics that selectively degrade disease-causing proteins.

Hinge Health

Series C in 2020
Hinge Health is a digital health company that designs and delivers technology-enabled musculoskeletal care for employees and self-insured employers. The platform combines wearable sensors, computer vision and a clinical team to provide digital physical therapy, guidance on behavior change, and access to orthopedic expertise via a single app. It targets back, neck, shoulder and joint pain and aims to improve access to high-quality care while reducing costs for clients. The solution supports self-management with remote monitoring and personalized programs, enabling physical therapists, health coaches and surgeons to coordinate care. Founded in 2015 and headquartered in San Francisco, it serves businesses and individuals seeking scalable MSK treatment and prevention.

TScan Therapeutics

Series B in 2020
TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

NeueHealth

Series D in 2019
NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

PharmEasy

Series D in 2019
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

NephroPlus

Series D in 2019
NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

Stuff That Works

Pre Seed Round in 2019
Founded in 2018, Stuff That Works develops an AI-based online platform that crowdsources data on chronic disease treatments. It offers a web-based questionnaire for quantitative analysis, publishing insights on conditions like clinical depression, diabetes, and fibromyalgia. The platform enables users to discuss insights and contributes to ongoing research.

TScan Therapeutics

Series B in 2019
TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Torch Dental

Venture Round in 2019
Torch Dental offers an all-in-one digital platform for dental practices to manage supply ordering and inventory efficiently. It simplifies the ordering process, allowing dentists to focus more on patient care.

Nym

Seed Round in 2019
Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Verata Health (Now Part of Olive)

Series A in 2019
Verata Health, now part of Olive, was established in 2017 and is headquartered in Bloomington, Minnesota, with additional offices in Minneapolis, Boston, and Orlando. The company specializes in developing artificial intelligence-based software solutions aimed at improving the prior authorization process for healthcare providers and payers. Its platform synthesizes clinical documentation and medical necessity rules to provide real-time decision recommendations, thereby streamlining manual tasks and enhancing efficiency. By removing barriers associated with prior authorization, Verata Health's technology enables healthcare providers, private practices, and pharmacies to take control of their revenue cycles, reduce write-offs, and ensure that patients receive timely care. The company has gained trust from health systems and providers across the country for its innovative approach to modernizing the healthcare authorization process.

Vlocity

Series C in 2019
Vlocity, Inc. specializes in developing industry-specific cloud and mobile software that facilitates digital transformation for businesses. Founded in 2014 and headquartered in San Francisco, California, Vlocity focuses on enhancing sales, service, and marketing efficiency while promoting operational agility and digital adoption. Its offerings include a range of applications tailored for various sectors, such as communications, media, health, insurance, energy, utilities, and government. Key products include Omniscript, which features drag-and-drop visual designers for data integration and script configuration, along with tools for customer order management and relationship management. Additionally, Vlocity provides comprehensive solutions such as Industry Console for streamlined customer interactions and Dataraptor for data transformations and transactional support. As of June 2020, Vlocity operates as a subsidiary of Salesforce.com, further enhancing its capabilities within the cloud software landscape.

Artemis Health

Series C in 2019
Artemis Health Inc. is a health data analytics company that specializes in providing self-insured employers with a comprehensive platform designed to optimize employee benefit programs. Founded in 2013 and headquartered in Salt Lake City, Utah, the company offers actionable insights into benefit programs, highlighting opportunities and gaps that enable employers to make informed decisions. Its platform allows users to identify issues within their benefits offerings, share insights with relevant stakeholders, and track the effectiveness of implemented solutions. By facilitating data-driven decision-making, Artemis Health helps employers enhance their programs while effectively managing healthcare expenditures and improving overall employee health and wellness coverage.

Verato

Series C in 2019
Verato develops cloud-based Software-as-a-Service products that clean, update, and link customer records within and across systems. Its core technology, referential matching, uses a curated database of identities to achieve high match rates even with incomplete or inconsistent data. Verato serves various industries, including healthcare, financial services, and the public sector, delivering accurate identity resolution, enrichment, verification, and governance capabilities.

Kymera Therapeutics

Series B in 2018
Kymera Therapeutics is a biotechnology company focused on targeted protein degradation. It employs a proprietary predictive modeling platform to discover novel small molecule therapeutics that selectively degrade disease-causing proteins.

PharmEasy

Series C in 2018
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

Centivo

Series A in 2018
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.

Subtle Medical

Seed Round in 2018
Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

Qventus

Series B in 2018
Qventus is an AI-powered software platform that optimizes hospital operations using real-time data analytics. The platform predicts issues, provides immediate recommendations, and prompts action by clinical and operations teams across emergency departments, operating rooms, preoperative areas, inpatient and outpatient settings, patient safety, and pharmacy. By turning data into actionable insights, it reduces manual work, improves patient flow, and optimizes resource use to unlock capacity and support hospital revenue. Based in Los Altos, California, Qventus was formerly analyticsMD

Welltok

Series E in 2018
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltok’s solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.

PharmEasy

Series C in 2018
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

DocsApp

Series A in 2017
DocsApp is an online doctor consultation platform. DocsApp is a mobile platform where people from India can consult a specialist MD Doctors with in 30 minutes in various specialisations through chat or call from the location of their convenience. DocsApp has specialist Doctors in the following specialisations.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Collective Medical

Series A in 2017
Collective Medical operates a real-time collaboration software platform for healthcare providers, connecting hospitals, clinics, health plans, and community organizations to share patient information and improve care coordination. The platform, used by hundreds of hospitals, health plans, and tens of thousands of providers nationwide, helps identify at-risk patients and facilitates collaborative care decisions, reducing emergency department visits and avoidable readmissions. Based in Salt Lake City, Collective Medical was founded in 2005 and is now a subsidiary of PointClickCare Corp.

Allena Pharmaceuticals

Post in 2017
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Groups Recover Together

Venture Round in 2017
Groups Recover Together, Inc. is a healthcare provider specializing in the treatment of opioid addiction through a combination of medication-assisted treatment and therapeutic services. Founded in 2014 and headquartered in Manchester, New Hampshire, the company operates private clinics across several states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its services include the administration of Suboxone (buprenorphine), weekly group therapy sessions, and personalized support to help patients set and achieve life goals. By fostering a supportive community, Groups Recover Together aims to empower individuals to regain control of their lives and pursue long-term recovery from opiate use disorder.

NeueHealth

Series B in 2017
NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

PharmEasy

Series B in 2017
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

PharmEasy

Series B in 2017
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

Verato

Series B in 2017
Verato develops cloud-based Software-as-a-Service products that clean, update, and link customer records within and across systems. Its core technology, referential matching, uses a curated database of identities to achieve high match rates even with incomplete or inconsistent data. Verato serves various industries, including healthcare, financial services, and the public sector, delivering accurate identity resolution, enrichment, verification, and governance capabilities.

OMsignal

Series B in 2016
OMsignal is a Montréal-based company founded in 2011 that specializes in manufacturing bio-sensing clothing designed to provide real-time access to medical-grade biometric data. The company's innovative apparel is embedded with sensors that monitor various health metrics, including heart rate, electrocardiography (ECG), respiration rhythms, and stress levels. This technology allows users to track their health and fitness seamlessly through a mobile application that displays data in real time. OMsignal's products aim to integrate health monitoring into everyday life, enabling individuals to maintain their well-being more effectively.

Florence Healthcare

Seed Round in 2016
Florence Healthcare, Inc. is a technology company that specializes in enhancing clinical research through innovative software solutions. Founded in 2014 and based in Atlanta, Georgia, the company develops tools that streamline the management and monitoring of clinical trial data. Its flagship product, the CloudBinder Suite, eliminates redundant data tasks for research sites and facilitates centralized and remote monitoring for sponsors. Additionally, Florence Healthcare offers CloudBinder Redaction software, which allows users to upload documents, redact sensitive patient information with ease, and share these documents with sponsors and contract research organizations. The company primarily serves pharmaceutical, biotechnology, and medical device sponsors, aiming to improve the efficiency and effectiveness of clinical trials.

Docent Health

Series A in 2016
Docent Health is a company based in Cambridge, Massachusetts, that specializes in developing software and mobile applications aimed at enhancing patient care and engagement for health systems. Its enterprise consumer engagement platform integrates digital and human interactions to provide personalized support for patients, guiding them according to their specific needs and preferences. By utilizing intelligent, real-time text messaging, Docent Health focuses on fostering lasting patient relationships and improving customer experiences. The company's approach combines insights from various industries, including retail and hospitality, to deliver customer-centric care that enhances patient satisfaction, increases customer lifetime value, and helps health systems grow their market share.

Alcresta Therapeutics

Series C in 2016
Alcresta Therapeutics, Inc. is dedicated to developing and commercializing enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's flagship product, RELiZORB, is a digestive enzyme cartridge that mimics pancreatic lipase, facilitating fat digestion and absorption in adults who require enteral tube feeding. Founded in 2011 and headquartered in Warren, New Jersey, Alcresta's innovative approach focuses on addressing the nutritional needs of infants, aging adults, and individuals facing acute or chronic health challenges. With a strong emphasis on research and development, the company leverages its expertise in adult and pediatric nutrition, protein manufacturing, and regulatory affairs to advance its product offerings and improve patient outcomes. Alcresta Therapeutics is committed to supporting better health through effective nutritional solutions for those with compromised digestive function.

NeueHealth

Series A in 2016
NeueHealth is a healthcare company dedicated to providing high-quality, coordinated care to aging and underserved populations. It operates through two segments: NeueCare, which manages risk in partnership with external payors, serving diverse patient populations; and NeueSolutions, offering technology, services, and clinical care solutions to empower providers.

PharmEasy

Series A in 2016
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health. The company operates an online platform that offers a range of healthcare services, including teleconsultation, medicine deliveries, and diagnostic test sample collections. By digitizing the pharmaceutical supply chain, PharmEasy connects patients with local pharmacies and diagnostic centers, facilitating access to essential medicines and healthcare products. This approach aims to make healthcare services more available, affordable, and accessible to patients.

Docent Health

Seed Round in 2016
Docent Health is a company based in Cambridge, Massachusetts, that specializes in developing software and mobile applications aimed at enhancing patient care and engagement for health systems. Its enterprise consumer engagement platform integrates digital and human interactions to provide personalized support for patients, guiding them according to their specific needs and preferences. By utilizing intelligent, real-time text messaging, Docent Health focuses on fostering lasting patient relationships and improving customer experiences. The company's approach combines insights from various industries, including retail and hospitality, to deliver customer-centric care that enhances patient satisfaction, increases customer lifetime value, and helps health systems grow their market share.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

OMsignal

Debt Financing in 2015
OMsignal is a Montréal-based company founded in 2011 that specializes in manufacturing bio-sensing clothing designed to provide real-time access to medical-grade biometric data. The company's innovative apparel is embedded with sensors that monitor various health metrics, including heart rate, electrocardiography (ECG), respiration rhythms, and stress levels. This technology allows users to track their health and fitness seamlessly through a mobile application that displays data in real time. OMsignal's products aim to integrate health monitoring into everyday life, enabling individuals to maintain their well-being more effectively.

Verato

Series A in 2015
Verato develops cloud-based Software-as-a-Service products that clean, update, and link customer records within and across systems. Its core technology, referential matching, uses a curated database of identities to achieve high match rates even with incomplete or inconsistent data. Verato serves various industries, including healthcare, financial services, and the public sector, delivering accurate identity resolution, enrichment, verification, and governance capabilities.

Welltok

Series D in 2015
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltok’s solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.

Rock Health

Seed Round in 2015
Founded in 2011, Rock Health is a venture capital firm based in San Francisco. It specializes in investing in and supporting startups working at the intersection of healthcare and technology, with a focus on digital health.

Allena Pharmaceuticals

Series B in 2014
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Atopix Therapeutics

Series A in 2014
Atopix Therapeutics Limited is a clinical-stage biopharmaceutical company based in Oxford, United Kingdom, focused on developing innovative anti-inflammatory medicines for the treatment of asthma, chronic allergic conditions, and other atopic diseases. Founded in 2012, the company specializes in a novel class of oral anti-allergic medications known as CRTH2 antagonists. Its lead candidate is currently undergoing a Phase 2 clinical trial aimed at addressing moderate to severe atopic dermatitis, with studies being conducted at several prominent dermatology centers across Europe. Atopix Therapeutics operates as a subsidiary of Chiesi Farmaceutici S.p.A.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Kurbo by WW

Series A in 2014
Kurbo Health, Inc. is a company based in Palo Alto, California, that specializes in developing a mobile application aimed at assisting overweight children and their families in managing weight effectively. Founded in 2013, Kurbo employs mobile technology and personalized coaching to help users track their food intake and adopt healthier lifestyles. The platform incorporates games, challenges, and virtual feedback, leveraging research from pediatric obesity experts to provide a scalable solution for weight management. By utilizing engaging mobile apps and web-based tools, Kurbo facilitates behavior modification and promotes healthier eating habits among adolescents, making it easier for them to control their weight.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.